Blog

Perspectives in Breast and Colorectal Cancer Research


NSABP Foundation

Peter Lucas, MD, discusses the use of correlative science post-clinical trials

Peter Lucas, MD, Associate Professor of Pathology at the University of Pittsburgh and Director of Pathology at NSABP Foundation


Peter Lucas, MD, Associate Professor of Pathology at the University of Pittsburgh and Director of Pathology and Principal Investigator at NSABP Foundation discusses the use of correlative science post-clinical trial and why clinical trials are important.

Previous Article Jame Abraham, MD, discusses the importance of patient participation in clinical trials
Next Article Dr. Charles Geyer discusses the NSABP B-59/GBG 96-GeparDouze trial
Print
1737

Name:
Email:
Subject:
Message:
x